Erector Spinae Plane Block for Analgesia During ESWL

Not Applicable

Recruiting

• Conditions: Renal Stone
• Interventions: Procedure: erector spinae plane block; Drug: Nalbuphine

• Registration Number: NCT07067996
• Lead Sponsor: Sohag University

Brief Summary

this study aims to compare between efficacy of erector spinae plane block and conventional multimodal analgesia in Extracorporeal shock wave lithotripsy

Detailed Description

Not available

Study Timeline

• Study Start: 2025-06-13
• Status Verified: 2025-07
• Study First Submitted: 2025-07-06
• Study First Submitted QC: 2025-07-06
• Last Update Submitted: 2025-07-06
• Study First Posted: 2025-07-16
• Last Update Posted: 2025-07-16
• Primary Completion: 2025-12-15
• Study Completion: 2025-12-15

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Adult Patients undergoing ESWL with 2-3 cm renal stones
• patients between the ages of 21 and 60,
• both sexes,
• BMI ≥18≤30 kg/m²
• Able to give informed consent.
• Patients older than 18 years with American Society of Anesthesiologists Physical Status I or II and

Exclusion Criteria

• Coagulopathy or on anticoagulants
• Infection at the ESPB injection site
• BMI ≥30 kg/m²
• Patient refusal.
• patients with advanced respiratory, renal, hepatic, neurological, or psychiatric disease, pregnant or nursing women.
• patients with a history of allergies to any study drugs

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
group A : will receive Erector Spinae Plane Block in the prone position after URS.	erector spinae plane block	* Patients in the block group (Group A)will receive the ESPB in the prone position after URS. ESPB needle insertion sites will be tolerated to the location of the stone, between T7-T10 vertebra levels. With these adjustments, Following the marking of the thoracic vertebrae levels with a marker pen, * The intervention will be initiated when the transverse processes and costotransverse joints on the relevant level will be distinguished using a high frequency(10-15 MHZ) linear ultrasound probe. The needle will be inserted at a 30° angle to the skin in an in-plane and craniocaudal fashion * Proper placement will be confirmed with ultrasonography and then 20 mL of 0.25% bupivacaine solution\&5 ml lidocaine 1% will be administered through the needle for intraoperative and postoperative anaglesia.
group B : will receive nalbuphine	Nalbuphine	•(Group B) patients will receive opioids ,nalbuphine( ,1 )mg/kg over 10 minutes then repeat the dose if needed \&monitoring patients for respiratory depression

Primary Outcome Measures

Name	Time	Method
This study aims to evaluate the efficacy of Erector Spinae Plane Block analgesia for patients undergoing ESWL &compare between it and conventional multimodal Analgesia .	6 hours postopertive	postoperative pain by visual analog score from 0 to 10 (where 0 indicates no pain and 10 the worst possible pain

Trial Locations

Locations (1)

Sohag University Hospital; 🇪🇬 Sohag, Egypt